0001811511-20-000001.txt : 20200515 0001811511-20-000001.hdr.sgml : 20200515 20200515151313 ACCESSION NUMBER: 0001811511-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 EFFECTIVENESS DATE: 20200515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ankyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001811511 IRS NUMBER: 843712498 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367078 FILM NUMBER: 20884357 BUSINESS ADDRESS: STREET 1: 83 NEWBURY STREET STREET 2: SUITE 4 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-823-2399 MAIL ADDRESS: STREET 1: 83 NEWBURY STREET STREET 2: SUITE 4 CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001811511 Ankyra Therapeutics, Inc. 83 NEWBURY STREET SUITE 4 BOSTON MA MASSACHUSETTS 02116 617-823-2399 DELAWARE None None Corporation true 2019 Tillman Gerngross 83 Newbury Street Suite 4 Boston MA MASSACHUSETTS 02116 Executive Officer Director Terrance McGuire 83 Newbury Street Suite 4 Boston MA MASSACHUSETTS 02116 Director Other Health Care Decline to Disclose 06b false 2020-05-04 false true false 0 14499994 14499994 0 false 4 0 0 0 false Ankyra Therapeutics, Inc. /s/ Tillman Gerngross Tillman Gerngross President 2020-05-12